WASHINGTON (AP) — Shares of drugmaker Sarepta Therapeutics continued to fall Tuesday after the company said it would comply ...

Dr. Peter Marks, the former director of the FDA’s Center for Biologics Evaluation and Research, urged public health leaders ...

What’s next: Nick Jacobson, an associate professor at Dartmouth College’s Geisel School of Medicine, who leads a laboratory on artificial intelligence and mental health, said that new regulatory ...

Replimune stock cratered Tuesday after the Food and Drug Administration unexpectedly rejected its experimental melanoma ...

Ice cream bars in Oregon and 22 other states are being recalled over potential listeria contamination.

Senate GOP leaders called for bipartisan cooperation to fund the government, but Senate Democrats have warned that trust is ...

The FDA asked Sarepta to pause all U.S. shipments of the DMD gene therapy Elevidys, and the company has agreed after initially refusing.

The FDA has issued a complete response letter to Replimune indicating it is unable to approve the biologics license ...

The FDA’s complete response letter cited concerns that the Phase I/II IGNYTE (CT03767348) trial in advanced melanoma was not ...

Costco reportedly puts its Kirkland-brand milk through rigorous testing that results in it not spoiling even past its printed ...

A new study from researchers at the University of Notre Dame and Indiana University shows that per- and polyfluoroalkyl chemicals (PFAS)—also known as “forever chemicals”—can be found in reusable ...

Alva Health CEO and Mexican immigrant Sandra Saldana aims to provide early detection for a leading cause of death and ...